Fennec Pharmaceuticals (FENC)

Fennec Pharmaceuticals (FENC) Financial Statements


Fennec Pharmaceuticals Financial Overview

Fennec Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $0.037; its P/E ratio is 182.70; Fennec Pharmaceuticals is scheduled to report earnings on August 9, 2024, and the estimated EPS forecast is $-0.02. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Sep 23Jun 23Mar 23Dec 22
Income Statement-
Total Revenue$ 9.73M$ 6.51M$ 3.33M$ 1.68M$ 1.53M
Gross Profit$ 9.05M$ 6.18M$ 3.18M$ 1.58M-
EBIT$ -1.77M$ -1.01M$ -4.62M$ -5.25M$ -6.11M
EBITDA$ -1.70M$ -939.00K$ -4.55M$ -5.18M$ -6.11M
Net Income Common Stockholders$ -2.68M$ -1.87M$ -5.44M$ -6.05M$ -6.86M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 13.27M$ 12.40M$ 14.96M$ 18.39M$ 23.77M
Total Assets$ 26.86M$ 19.03M$ 19.44M$ 21.82M$ 26.94M
Total Debt$ 29.73M$ 24.72M$ 24.68M$ 24.66M$ 24.90M
Net Debt$ 16.46M$ 12.32M$ 9.72M$ 6.27M$ 1.13M
Total Liabilities$ 38.49M$ 29.56M$ 29.16M$ 29.16M$ 29.51M
Stockholders Equity$ -11.62M$ -10.53M$ -9.73M$ -7.34M$ -2.57M
Cash Flow-
Free Cash Flow$ -4.86M-$ -3.95M$ -5.58M$ -6.80M
Operating Cash Flow$ -4.86M-$ -3.95M$ -5.58M$ -6.80M
Investing Cash Flow-----
Financing Cash Flow$ 5.73M-$ 514.00K$ 193.00K$ 824.00K
Currency in USD

Fennec Pharmaceuticals Earnings and Revenue History

Fennec Pharmaceuticals Debt to Assets

Fennec Pharmaceuticals Cash Flow

Fennec Pharmaceuticals Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis